相关产品推荐更多 >

KDEL受体抗体:偶联ATTO 633|KDEL Receptor Antibody: ATTO 633
询价
RANBP10 抗体-RANBP10 Antibody
¥22
iFluor™ 405 Anti-human CD169 Antibody *7-239*/iFluor™ 405 Anti-human CD169 Antibody *7-239*/iFluor™ 405 Anti-human CD169 Antibody *7-239*
询价
Abl1 抗体(pTyr469):偶联ATTO 655|Abl1 Antibody (pTyr469): ATTO 655
询价![IGF-1 抗体 [SPM406]-IGF-1 Antibody [SPM406]](https://img1.dxycdn.com/p/s14/2023/1218/191/8638588858174956371.jpg!wh200)
IGF-1 抗体 [SPM406]-IGF-1 Antibody [SPM406]
¥22
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
This TAK1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 215-241 amino acids from the C-terminal region of human TAK1L.
- 保存条件:
Store at 4℃ for three months and -20℃, stable for up to one year
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
兔
- 应用范围:
WB
- 抗体英文名:
TAK1L Antibody
- 抗体名:
TAK1L Antibody
- 规格:
400ul
TAK1L 抗体,TAK1L Antibody,TAK1L 抗体,TAK1L Antibody
产品名称:TAK1L 抗体-TAK1L Antibody
产品货号:PSI-60-312-400ul
产品规格:400ul
背景资料:TAK1L plays a critical role in the TGF beta signaling transduction pathway.
保存建议:TAK1L 抗体-TAK1L AntibodyStore at 4℃ for three months and -20℃, stable for up to one year
应用类型:WB
点击:TAK1L 抗体-TAK1L Antibody查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Cell Metab:西京医院王琳教授团队报道非酒精性脂肪肝炎新靶点
Metabolism 上在线发表了题为 Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1 的研究成果 (4)。该研究发现 E3 泛素连接酶 TRIM16 通过促进 p-TAK1 的泛素化依赖性降解,改善 NASH 进展过程中的脂质积累和炎症。 图片来源:Cell Metabolism研究内容肝细胞的脂肪毒性诱导 TRIM16 的表达脂肪毒性是脂质过度积累
Purification of Antibody Light Chains by Metal Affinity and Protein L Chromatography
Immobilized metal affinity chromatography (IMAC), introduced in 1975 (1 ), relies on the formation of coordinate bonds between metal ions immobilized on a suitable support and electron donor groups in proteins. A polyhistidine tag
Analysis and Purification of Antibody Fragments Using Protein A, Protein G, and Protein L
Today, monoclonal antibodies (mAbs) form the largest category of biopharmaceuticals in clinical trials and their number is expanding rapidly (DataMonitor 2007). The antibodies or functional antibody fragments are being produced in artificial
技术资料暂无技术资料 索取技术资料







